Asia Pacific Acute Lung Injury Market revenue to cross $174.61 Million by 2028, Says Business Market Insights

Asia Pacific Acute Lung Injury Market is expected to grow from US$ 122.16 Million in 2021 to US$ 174.61 million by the year 2028. This represents a CAGR of 5.2% from the year 2021 to 2028.

Browse Full Report With TOC @ https://www.businessmarketinsights.com/reports/asia-pacific-acute-lung-injury-market/?utm_source=OpenPR&utm_medium=10356

APAC Acute Lung Injury market is analyzed based countries such as China, Japan, India, Australia, South Korea, and the rest of APAC. China held the largest share of the market in 2021. The growth of the market in the country is attributed to the higher prevalence of respiratory and other various other lung diseases. China is among the most populated countries in the world, and it is a country with a maximum number of patients living with respiratory disorders. The country also has experienced a significant rise in the elderly population; therefore, lung-associated diseases are the leading causes of death among older people.

According to a recent study- “Chronic Illness and Ageing in China”, China's population is aging, and chronic illnesses are increasingly prevalent. From 2010 to 2040, it is predicted that the proportion of people aged 60 years plus in China will rise from 12.4% (168 million) to 28% (402 Million). Approximately 80% of deaths in China in people aged 60 years are from chronic Non-Communicable Diseases (NCDs); the most prevalent diseases are Ischemic Heart Disease, Chronic Obstructive Pulmonary Disease (COPD), Stroke, and Type 2 Diabetes. Behavioral risks including smoking, sedentary behavior, alcohol consumption, and poor dietary intake contribute significantly to these conditions. Given that chronic diseases in the region are gradually elevating, need for advance treatment is propelling in China. This factor has offered a significant boost to the adoption of acute lung injury therapies. Thus, the collective impact of the above-mentioned factors is expected to augment the growth of the market in region.

Request for Sample Copy of this Asia Pacific Acute Lung Injury Market research report at – https://www.businessmarketinsights.com/sample/TIPRE00025718/?utm_source=OpenPR&utm_medium=10356

Some of the companies competing in the Asia Pacific Acute Lung Injury Market are: Angion, GlaxoSmithKline Plc, ReAlta Life Sciences, Inc., Stemedica Cell Technologies, Inc, Windtree Therapeutics, Inc.

The high prevalence of respiratory conditions is associated with the decrease in the size of the upper airway lumen in the aging population. Lung disorders are among the most common medical conditions across the region. People suffer from various sorts of respiratory diseases. Smoking, infections, and genetic factors are among the common factors responsible for respiratory disorders. Medical conditions such as COPD, asthma, chronic bronchitis, cystic fibrosis, and lung cancer are significant public health burdens. In addition, the World Health Organization (WHO) states that millions of people die from lung cancer every year, making it the most common lethal infectious disease. In addition, 91% of the population lives in cities and places where the air quality is not optimum, as recommended by the WHO. Patients suffering from these respiratory disorders commonly experience difficulty in breathing. The respiratory failure associated with acute lung injury, or the acute respiratory distress syndrome (ARDS) is one of the most critical contributors to postoperative mortality. Moreover, state, and local health departments, and other clinical and public health associates continue to monitor smoking e-cigarette or vaping product use associated lung injury (EVALI). Thus, all the above-mentioned factors are expected to result in the growth of the APAC acute lung injury market during the forecast period.

APAC Acute Lung Injury Market - By Country:
1. China
2. Japan
3. India
4. Australia
5. South Korea
6. Rest of APAC

APAC Acute Lung Injury Market - By Applications:
1. Hospitals
2. Ambulatory Surgery Centers

The final report will add the analysis of the Impact of Covid-19 in this report Asia Pacific Acute Lung Injury Market.

In case of COVID-19, APAC is highly affected specially India. As of September 2021, the COVID-19 cases reached 56.5 million in APAC, according to the United Nations Office for the Coordination of Humanitarian Affairs (UNOCHA). COVID-19 infection has been a serious problem in the patients with acute lung injury. According to the clinical data of infected patients in Asia, radiologic evidence of lung edema is common and deserves clinical attention. Lung edema is a manifestation of acute lung injury (ALI) and may progress to hypoxemia and potentially acute respiratory distress syndrome (ARDS). Patients diagnosed with ARDS and ALI have poorer prognosis and potentially higher mortality. Although no effective treatment is formally approved for COVID-19 infection, support of ventilation with oxygen therapy and sometimes mechanical ventilation is often required. Treatment with systemic and/or local glucocorticoids might be helpful to alleviate the pulmonary inflammation and edema, which may decrease the development and/or consequences of ARDS. For instance, a study combining data from China and Italy indicated that 27% of highly infected COVID-19 patients required assisted ventilation and had a 21% death rate. As a result, the acute lung injury market in the region has seen great expansion due to the COVID-19 impact.

Purchase a Copy of this Asia Pacific Acute Lung Injury Market research report at – https://www.businessmarketinsights.com/buy/single/TIPRE00025718/?utm_source=OpenPR&utm_medium=10356

Reasons for buy this Report
• To understand the APAC acute lung injury market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC acute lung injury market
• Efficiently plan M&A and partnership deals APAC acute lung injury market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC acute lung injury market
• Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.

Contact US:
Business Market Insights
Phone: +442081254005
E-Mail ID: sales@businessmarketinsights.com
Web URL: https://www.businessmarketinsights.com/
LinkedIn URL: https://www.linkedin.com/company/business-market-insights/

About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

This release was published on openPR.